1-2 of 2
Kevin O. McNerney
Close
Sort by
Journal Articles

HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL

Clinical Trials & Observations
Kevin O. McNerney, Stephanie J. Si Lim, Kyle Ishikawa, Alexandra Dreyzin, Anant Vatsayan, John J. Chen, Christina Baggott, Snehit Prabhu, Holly L. Pacenta, Christine Philips, Jenna Rossoff, Heather E. Stefanski, Julie-An Talano, Amy Moskop, Michael Verneris, Doug Myers, Nicole A. Karras, Patrick Brown, Challice L. Bonifant, Muna Qayed, Michelle Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Susanne H. C. Baumeister, Vanessa A. Fabrizio, Vasant Chinnabhandar, Emily Egeler, Sharon Mavroukakis, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2758–2771.
https://doi.org/10.1182/bloodadvances.2022008893
Published: 2023
Includes: Supplemental data
Journal Articles

Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations

Clinical Trials & Observations
Caroline Diorio, Kevin O. McNerney, Michele Lambert, Michele Paessler, Elizabeth M. Anderson, Sarah E. Henrickson, Julie Chase, Emily J. Liebling, Chakkapong Burudpakdee, Jessica H. Lee, Frances B. Balamuth, Allison M. Blatz, Kathleen Chiotos, Julie C. Fitzgerald, Therese M. Giglia, Kandace Gollomp, Audrey R. Odom John, Cristina Jasen, Tomas Leng, Whitney Petrosa, Laura A. Vella, Char Witmer, Kathleen E. Sullivan, Benjamin L. Laskin, Scott E. Hensley, Hamid Bassiri, Edward M. Behrens, David T. Teachey
Journal: Blood Advances
Blood Adv (2020) 4 (23): 6051–6063.
https://doi.org/10.1182/bloodadvances.2020003471
Published: 2020
Includes: Supplemental data